LPL Financial
DYN icon

LPL Financial’s Dyne Therapeutics DYN Stock Holding History

LPL Financial’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$333K Buy
18,364
+3,114
+20% +$53.7K ﹤0.01% 5119
2025
Q4 		$298K Buy
+15,250
New +$289K ﹤0.01% 5148
2024
Q2 		– Sell
-15,114
Closed -$429K – 5050
2024
Q1 		$429K Buy
+15,114
New +$342K ﹤0.01% 3904

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

LPL Financial's DYN Position: Q1 2026 in Review

LPL Financial increased its Dyne Therapeutics (DYN) stake by 20% in Q1 2026, buying an estimated $53.7K and bringing the position to 18,364 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #5119.

LPL Financial first reported a position in DYN in Q1 2024 and has held it in 3 quarters since. The position peaked at $429K in Q1 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • LPL Financial held 18,364 shares of Dyne Therapeutics worth $333K as of Q1 2026.
  • LPL Financial bought 3,114 Dyne Therapeutics shares in Q1 2026, an estimated $53.7K.
  • Dyne Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5119 holding.
  • LPL Financial first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • LPL Financial's Dyne Therapeutics position peaked at $429K in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.